Mechanisms of sunitinib malate (SU) resistance in gastrointestinal stromal tumors (GISTs)Michael C. Heinrich, Jonathan A. Fletcher, Chandrajit P. Raut et al.|Journal of Clinical Oncology|2007Cited by 19
Abstract B184: HSP90 inhibitor STA-9090 potently suppresses heterogeneous KIT kinase-domain mutations responsible for gastrointestinal stromal tumor progression during imatinib therapyJonathan A. Fletcher, George D. Demetri, Maria Dêbiec‐Rychter et al.|Molecular Cancer Therapeutics|2009Cited by 3